PS
Paidiwar Srinivas
About Paidiwar Srinivas
Data last updated:
Paidiwar Srinivas is a Director at Venkata Krishna Enterprises Private Limited (since 2019), Director at Sai Sridhar Pharma Private Limited (since 2017) and Director at Sidson Pharma Distributors Private Limited (since 2017), and holds 7 more current directorships. The companies operate in Pharma, Consumer Electronics & Durables and Financial Services. The 9 current companies with reported revenue have a combined latest revenue of ₹1,069 Cr; the largest is Venkata Krishna Enterprises Private Limited at ₹414 Cr (FY 2025). Earlier, Paidiwar Srinivas was a Director at Optival Health Solutions Private Limited (2005–2011) and Director at Mhs Pharmaceuticals Private Limited (from 2011) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Jul 2019 | 2010 | ₹414 Cr (FY 2025) | Active | |
| Director | 16 Oct 2017 | 2007 | ₹349 Cr (FY 2025) | Active | |
| Director | 15 Oct 2017 | 2014 | ₹140 Cr (FY 2025) | Active | |
| Director | 27 Aug 2019 | 2011 | ₹128 Cr (FY 2025) | Active | |
| Director | 15 Mar 2017 | 2013 | ₹23.95 Cr (FY 2025) | Active | |
| Director | 03 Aug 2013 | 2007 | ₹13.13 Cr (FY 2025) | Active | |
| Director | 14 Jul 2022 | 2022 | ₹1.16 Cr (FY 2025) | Active | |
| Director | 26 May 2024 | 2016 | ₹3.7 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Dec 2005 | 2005 | ₹6,059 Cr (FY 2025) | Active | |
| Director | 04 Apr 2011 | 2008 | ₹72.2 Lakh (FY 2024) | Amalgamated | |
| Director | 04 Apr 2011 | 2009 | ₹513 Cr (FY 2017) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Paidiwar Srinivas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Phani Srinivas Ramella | 03273162 | Venkata Krishna Enterprises Private Limited , Sai Sridhar Pharma Private Limited and 4 more | Director |
| Udaya Lakshmi Tadepalli | 06976534 | Venkata Krishna Enterprises Private Limited , Sai Sridhar Pharma Private Limited | Director |
| Satya Murali Krishna Kammila | 01499290 | Sai Sridhar Pharma Private Limited , Sidson Pharma Distributors Private Limited and 7 more | Director |
| Bhaskar Reddy Cherukupalli | 00926550 | Wynclark Pharmaceuticals Private Limited , Kalyani Meditimes Private Limited and 1 more | Director |
| Riti Gupta | Wynclark Pharmaceuticals Private Limited | Company Secretary | |
| Ritik Jain | Wynclark Pharmaceuticals Private Limited | Company Secretary | |
| Sujit Kumar Mahato | 07599067 | Wynclark Pharmaceuticals Private Limited | Cfo |
| Sujit Kumar Mahato | Wynclark Pharmaceuticals Private Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Paidiwar Srinivas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paidiwar Srinivas
Paidiwar Srinivas currently holds 10 directorships: Venkata Krishna Enterprises Private Limited (Director, since 02 Jul 2019, revenue ₹414 Cr (FY 2025)); Sai Sridhar Pharma Private Limited (Director, since 16 Oct 2017, revenue ₹349 Cr (FY 2025)); Sidson Pharma Distributors Private Limited (Director, since 15 Oct 2017, revenue ₹140 Cr (FY 2025)); Deccan Medisales Private Limited (Director, since 27 Aug 2019, revenue ₹128 Cr (FY 2025)); Dureleg Manufacturing Private Limited (Director, since 15 Mar 2017, revenue ₹23.95 Cr (FY 2025)); and 5 more.
Paidiwar Srinivas was first appointed on 31 Dec 2005 as Director at Optival Health Solutions Private Limited. The most recent appointment on record is 26 May 2024 at Kalyani Meditimes Private Limited.
The 9 current companies of Paidiwar Srinivas that report revenue have a combined latest revenue of ₹1,069 Cr: Venkata Krishna Enterprises Private Limited ₹414 Cr (FY 2025); Sai Sridhar Pharma Private Limited ₹349 Cr (FY 2025); Sidson Pharma Distributors Private Limited ₹140 Cr (FY 2025); Deccan Medisales Private Limited ₹128 Cr (FY 2025); Dureleg Manufacturing Private Limited ₹23.95 Cr (FY 2025); and 4 more.
Paidiwar Srinivas held 3 earlier board appointments: Optival Health Solutions Private Limited (Director, 31 Dec 2005 to 04 Apr 2011); Mhs Pharmaceuticals Private Limited (Director, from 04 Apr 2011); Ritemed Pharma Retail Private Limited (Director, from 04 Apr 2011).
The current boards of Paidiwar Srinivas's companies include Phani Srinivas Ramella (Venkata Krishna Enterprises Private Limited), Udaya Lakshmi Tadepalli (Venkata Krishna Enterprises Private Limited), Satya Murali Krishna Kammila (Sai Sridhar Pharma Private Limited), Bhaskar Reddy Cherukupalli (Wynclark Pharmaceuticals Private Limited), Riti Gupta (Wynclark Pharmaceuticals Private Limited), Ritik Jain (Wynclark Pharmaceuticals Private Limited), among others.